Free Trial

Healthpeak Properties (NYSE:DOC) Stock Rating Lowered by Wall Street Zen

Healthpeak Properties logo with Finance background

Wall Street Zen lowered shares of Healthpeak Properties (NYSE:DOC - Free Report) from a hold rating to a sell rating in a report published on Monday morning.

DOC has been the subject of a number of other reports. Argus reiterated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Robert W. Baird lowered their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Wedbush lowered their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Scotiabank lowered their price objective on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research report on Monday, May 12th. Finally, Wells Fargo & Company decreased their target price on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $23.27.

Check Out Our Latest Stock Report on DOC

Healthpeak Properties Stock Performance

Shares of DOC traded down $0.25 during mid-day trading on Monday, hitting $17.97. The company's stock had a trading volume of 6,445,136 shares, compared to its average volume of 5,336,337. Healthpeak Properties has a one year low of $16.64 and a one year high of $23.26. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35. The firm has a market capitalization of $12.48 billion, a PE ratio of 44.93, a price-to-earnings-growth ratio of 2.08 and a beta of 1.03. The stock's 50-day moving average is $17.43 and its two-hundred day moving average is $19.00.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The firm had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. Healthpeak Properties's quarterly revenue was up 15.9% compared to the same quarter last year. During the same period last year, the business earned $0.45 earnings per share. As a group, sell-side analysts anticipate that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

Insider Activity

In other Healthpeak Properties news, Director Tommy G. Thompson acquired 5,777 shares of the business's stock in a transaction dated Wednesday, May 28th. The shares were acquired at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director directly owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Scott M. Brinker acquired 11,337 shares of the business's stock in a transaction dated Monday, April 28th. The shares were acquired at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the acquisition, the chief executive officer directly owned 201,863 shares in the company, valued at $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 29,764 shares of company stock worth $521,909 in the last 90 days. Corporate insiders own 0.23% of the company's stock.

Institutional Investors Weigh In On Healthpeak Properties

Several institutional investors have recently bought and sold shares of DOC. Norges Bank bought a new stake in Healthpeak Properties in the 4th quarter valued at approximately $166,804,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Healthpeak Properties by 584.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock worth $186,405,000 after purchasing an additional 7,872,150 shares during the last quarter. Nuveen LLC acquired a new position in shares of Healthpeak Properties during the 1st quarter worth approximately $124,113,000. Resolution Capital Ltd acquired a new position in shares of Healthpeak Properties during the 4th quarter worth approximately $122,795,000. Finally, Long Pond Capital LP acquired a new position in shares of Healthpeak Properties during the 4th quarter worth approximately $86,885,000. Institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Further Reading

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines